Page 176 - rcv31n3.vp
P. 176

Neuropatía autonómica cardiovascular en diabetes                          Revista Uruguaya de Cardiología
                                     José Aníbal Manfredi Carabetti                                          Volumen 31 | nº 3 | Diciembre 2016




                                                    Circulation  2009;  119(22):  2886–93.  doi:  17. American Diabetes Association, American
                                                    http://dx.doi.org/10.1161/CIRCULATIONAHA.108.837  Academy of Neurology. Report and recommenda-
                                                    369.                                        tions of the San Antonio Conference on Diabetic
                                                                                                Neuropathy. Diabetes Care. 1988 Jul; 11(7): 592–7.
                                                7.  Gæde P, Vedel P, Larsen N, Jensen GVH, Par-
                                                                                                doi: http://dx.doi.org/10.2337/diacare.11.7.592.
                                                    ving H-H, Pedersen O. Multifactorial intervention
                                                    and cardiovascular disease in patients with type 2  18. American Diabetes Association, American
                                                    diabetes. N Engl J Med. 2003 Jan;348(5):383-93.  Academy of Neurology. Proceedings of a consen-
                                                                                                sus development conference on standardized measu-
                                                8.  Gæde P, Lund-Andersen H, Parving H-H, Pe-
                                                                                                res in diabetic neuropathy. Diabetes Care. 1992 Aug;
                                                    dersen O. Effect of a multifactorial intervention on
                                                                                                15 Suppl 3:1080-107.
                                                    mortality in type 2 diabetes. N Engl J Med. 2008 Feb
                                                    7; 358(6):580-91. doi: 10.1056/NEJMoa0706245.  19. Assessment: clinical autonomic testing report of the
                                                9.  Dimitropoulos G, Tahrani AA, Stevens MJ.    Therapeutics and Technology Assessment Subcom-
                                                    Cardiac autonomic neuropathy in patients with dia-  mittee of the American Academy of Neurology. Neu-
                                                    betes mellitus. World J Diabetes. 2014 Feb 15; 5(1):  rology 1996 Mar; 46: 873–80.
                                                    17-39. doi:10.4239/wjd.v5.i1.17.        20. American Diabetes Association, American
                                                10. Vinik AI, Maser RE, Mitchell BD, Freeman R.  Academy of Neurology. Report and recommenda-
                                                    Diabetic Autonomic Neuropathy. Diabetes Care.  tions of the San Antonio conference on diabetic neu-
                                                    2003 May; 26(5):1553-79.                    ropathy. Diabetes. 1988 Jul; 37(7):1000-4. doi:
                                                    doi: http://dx.doi.org/10.2337/diacare.26.5.1553.  http://dx.doi.org/10.2337/diab.37.7.1000.
                                                11. Astrup AS, Tarnow L, Rossing P, Hansen BV,  21. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feld-
                                                    Hilsted J, Parving H-H. Cardiac autonomic neuro-  man EL, Freeman R, et al. Diabetic neuropathies:
                                                    pathy predicts cardiovascular morbidity and morta-  a statement by the American Diabetes Association.
                                                    lity in type 1 diabetic patients with diabetic nephro-  Diabetes Care. 2005 Apr; 28(4): 956–62.
                                                    pathy. Diabetes Care. 2006 Feb 1; 29(2): 334–9. doi:  doi: http://dx.doi.org/10.2337/diacare.28.4.956.
                                                    http://dx.doi.org/10.2337/diaca-
                                                                                            22. Vinik AI, Ziegler D. Diabetic Cardiovascular Auto-
                                                    re.29.02.06.dc05-1242.
                                                                                                nomic Neuropathy. Circulation. 2007 Jan 23;
                                                12. Maser RE, Mitchell BD, Vinik AI, Freeman R.  115(3):387-97.
                                                    The association between cardiovascular autonomic
                                                                                            23. Mustonen J, Uusitupa M, Mäntysaari M, Länsi-
                                                    neuropathy and mortality in individuals with diabe-
                                                                                                mies E, Pyörälä K, Laakso M. Changes in autono-
                                                    tes: a meta-analysis. Diabetes Care. 2003 Jun ; 26(6):
                                                                                                mic nervous function during the 4 year follow-up in
                                                    1895–901.  doi:  http://dx.doi.org/10.2337/diaca-
                                                                                                middle-aged diabetic and nondiabetic subjects ini-
                                                    re.26.6.1895.
                                                                                                tially free of coronary heart disease. J Intern Med.
                                                13. Wheeler SG, Ahroni JH, Boyko EJ. Prospective  1997 Mar; 241(3):231-9.
                                                    study of autonomic neuropathy as a predictor of mor-  doi: 10.1046/j.1365-2796.1997.102116000.x .
                                                    tality in patients with diabetes. Diabetes Res Clin
                                                                                            24. Xu W, Zhu Y, Yang X, Deng H, Yan J, Lin S, et al.
                                                    Pract. 2002 Nov; 58(2): 131–8.
                                                                                                Glycemic variability is an important risk factor for
                                                    doi: http://dx.doi.org/10.1016/S0168-8227(02)00128-6.
                                                                                                cardiovascular autonomic neuropathy in newly diag-
                                                14. Young LH, Wackers FJT, Chyun DA, Davey JA,  nosed type 2 diabetic patients. Int J Cardiol. 2016 Jul
                                                    Barrett EJ, Taillefer R, et al; DIAD Investiga-  15; 215:263–8. doi: http://dx.doi.org/10.1016/j.ij-
                                                    tors. Cardiac outcomes after screening for asympto-  card.2016.04.078.
                                                    matic coronary artery disease in patients with type 2
                                                    diabetes The DIAD Study: A randomized controlled  25. Maarek A, Gandhi PG, Rao GHR. Identifying Au-
                                                    trial. JAMA. 2009 Apr 15;301(15):1547-55.   tonomic Neuropathy and Endothelial Dysfunction in
                                                    doi:10.1001/jama.2009.476.                  Type II Diabetic Patients. EC Neurology. 2015; 2(2):
                                                                                                63-78.
                                                15. Ewing DJ, Martyn CN, Young RJ, Clarke BF.
                                                    The value of cardiovascular autonomic function  26. Sayeski PP, Kudlow JE. Glucose metabolism to
                                                    tests: 10 year experience in diabetes. Diabetes Care.  glucosamine is necessary for glucose stimulation of
                                                    1985 Sep 1; 8(5):491-8.                     transforming growth factor-alpha gene transcrip-
                                                    doi: http://dx.doi.org/10.2337/diac.8.5.XXXVIII.  tion. J Biol Chem. 1996 Jun 21; 271:15237-43. doi:
                                                                                                10.1074/jbc.271.25.15237.
                                                16. Low PA, Denq J-C, Opfer-Gehrking TL, Dyck
                                                    PJ, O’Brien PC, Slezak JM. Effect of age and gen-  27. Sacre JW, Franjic B, Jellis CL, Jenkins C,
                                                    der on sudomotor and cardiovagal function and blood  Coombes JS, Marwick TH. Association of cardiac
                                                    pressure response to tilt in normal subjects. Muscle  autonomic neuropathy with subclinical myocardial
                                                    Nerve. 1997 Dec; 20(12): 1561-8.            dysfunction in type 2 diabetes. J Am Coll Cardiol
                                                    doi:10.1002/(SICI)1097-4598(199712)20:12<1561::  Img. 2010 Dic 3;3(12):1207–15.
                                                    AID-MUS11>3.0.CO;2-3.                       doi:10.1016/j.jcmg.2010.09.014.
                                    520
   171   172   173   174   175   176   177   178   179   180   181